Cerenome (CNSY) Net Margin Growth (3y) (2014 - 2026)
Powered by 
Analysis
Cerenome (CNSY) Net Margin Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | -374.00 |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | -44.00 |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 6,620.00 |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | -13,815.00 |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 7,793.00 |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 9,934.00 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -5,319.00 |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 31,387.00 |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | -211,324.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -211,324.00 |
| Mar 31, 2026 | 27,392.00 |
| Dec 31, 2025 | 329,731.00 |
| Sep 30, 2025 | 686,969.00 |
| Mar 31, 2019 | -7,743.00 |
| Dec 31, 2018 | -22,836.00 |
| Sep 30, 2018 | -65,100.00 |
| Jun 30, 2018 | -83,004.00 |
| Mar 31, 2018 | 185,624.00 |
| Dec 31, 2017 | -96,775.00 |
| Sep 30, 2017 | 78,244.00 |
| Jun 30, 2017 | 64,077.00 |
| Mar 31, 2017 | -26,775.00 |
| Dec 31, 2016 | 3,611.00 |
| Sep 30, 2016 | -14,531.00 |
| Jun 30, 2016 | -7,067.00 |
| Mar 31, 2016 | 13,439.00 |
| Dec 31, 2015 | -8,728.00 |
| Sep 30, 2015 | 104,996.00 |
| Jun 30, 2015 | 67,724.00 |